• About us
• Contact

Advertisement

Product › Details

venture capital

	Next higher product group	private equity

Record changed: 2024-10-07

Advertisement

More documents for venture capital

• [1] Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin....
• [2] Clock Bio Ltd.. (10/9/24). "Press Release: clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors". Cambridge....
• [3] a:head bio AG. (10/9/24). "Press Release: a:head Secures Pre-Series A Funding and Appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board". Vienna....
• [4] Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford....
• [5] LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge....
• [6] Aitiologic GmbH. (10/1/24). "Press Release: Aitiologic Emerges from Stealth Mode with over €2.5M in Funding to Advance AI-powered Liquid Biopsy Platform for Early Disease Detection". Vienna....
• [7] 1BillionLives GmbH (d/b/a Flinn). (9/30/24). "News (LinkedIn Post): Exciting News from the Flinn.ai! We Have Secured €6M in Seed Funding, Adding Up to €10M Raised in Less than 18 Months [...]"....
• [8] Sequentia Biotech S.L.. (9/27/24). "Press Release: Sequentia Biotech Secures €10 Million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications". Barcelona....
• [9] Genespire S.r.l.. (9/25/24). "Press Release: Genespire Raises €46.6 Million (~$52 Million) in a Series B Round to Advance Its First Pediatric in-vivo Gene Therapy into the Clinic". Milan....
• [10] Aptadir Therapeutics. (9/24/24). "Press Release: Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors". Milan....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.